Management of DKA Presentation

download Management of DKA Presentation

of 46

Transcript of Management of DKA Presentation

  • 8/7/2019 Management of DKA Presentation

    1/46

    MUHAMMED YESUF(M D)

    University of Gondar

  • 8/7/2019 Management of DKA Presentation

    2/46

    Presentation outliney Overviewy History

    y Epidemiologyy Pathophysiolgyy Clinical presentationy Dx and DDXy Rx

    y Monitoringy DKA Resolutiony Complicationsy Sick day rule

  • 8/7/2019 Management of DKA Presentation

    3/46

    Overviewy One of the common and life threatening acute

    complication of DM

    y Results from absolute insulin deficiency and itsresultant metabolic alterations

    yAccounts for 16% of DM related deaths

  • 8/7/2019 Management of DKA Presentation

    4/46

    Historyy First full description

    y Jullius Dreschfeld 1886

    y Universally fatal till 1920sy By 1930 MR 29%

    y By 1950 MR

  • 8/7/2019 Management of DKA Presentation

    5/46

    Epidemiologyy In type I

    y In young (

  • 8/7/2019 Management of DKA Presentation

    6/46

    Pathophysiologyy Insulin deficiency

    y Increased counter regulatory hormones (Glucagon,cathecolamins, cortisol, GH)

    Hyperglycemiay Impaired glucose utilization

    y Decreased insulin - decreased GLUT 4

    y Increased glucose productiony

    Gluconogenesisy Glyconogynolysis

    Hyperglycemiay Draws water from cells Volume depletion

    y Induces glucosuria with osmotic diuresis

  • 8/7/2019 Management of DKA Presentation

    7/46

    Volume depletion/ DHN depends on

    y Duration of hyperglycemia

    y Level of renal functiony Pt fluid intake

  • 8/7/2019 Management of DKA Presentation

    8/46

    Ketoacidosis

    keton bodies from increase lipolysis

    Decreased insulin

    Lipolysis

    Glycerol FFA

    Maloyl CoA

    Gluconogenesis TG, VLDL KB

  • 8/7/2019 Management of DKA Presentation

    9/46

    y Electrolyte disturbance

    Na

    balance of water shift from ICF to ECF Vs Osmoticdiuresis

    hyperglycemia causes a sodium drop of 1meq ofNa for every 62mg/dl rise of glucose

    corrected serum Na = measured Na + (SG(mg/dl) /42)or

    = measured Na + (SG (mmol/L) /2.3)

  • 8/7/2019 Management of DKA Presentation

    10/46

  • 8/7/2019 Management of DKA Presentation

    11/46

    y K

    Measured K can be high, low, normal. Generally there is

    3-5 mg/Kg lossurinary loss

    GI loss

    Loss from cells

    Serum K is increase b/c of decreased insulin andhyperosmolarity. Acidosis plays less role

  • 8/7/2019 Management of DKA Presentation

    12/46

    y Phosphate

    Negative P balance

    decreased intakephoshaturia

    Serum level can be normal or increased b/c of

    decreased insulin

    acidosis

    y Bicarbonate

    Always low

  • 8/7/2019 Management of DKA Presentation

    13/46

    Table : Total body deficits of water and electrolytes in DKA

    DKA

    Total water(l) 6

    Water(ml/kg) 100

    Na(meq/kg) 7-10

    Cl(meq/kg) 3-5

    K(meq/kg) 3-5

    Po4(mmol/kg) 5-7

    Mg(meq/kg) 1-2Ca(meq/kg) 1-2

  • 8/7/2019 Management of DKA Presentation

    14/46

    Clinical presentationy Sx

    y Early poly Sx

    Wt lossy Later neurologic Sx (lethargy, focal signs, obtundation,

    Coma)

    Because of increased plasma osmolality. It

    occurs when the effective plasma osmolality is 320 330.And it can be calculated as

  • 8/7/2019 Management of DKA Presentation

    15/46

    Effective Posm= [2*Na (meq/L)] + [glucose (mg/dl)/18]

    Or

    = [2*Na (mmol/L)] + [glucose (mmol/L)]

    Effective Posm= [measured Posm]-[BUN (mg/dl) /2.8]

    Or

    = [measured Posm]-[BUN (mmol/L)]

  • 8/7/2019 Management of DKA Presentation

    16/46

    yAbdominal pain, nausea and vomiting

    Abd pain associated with the degree of acidosis and could

    be due to delayed gastric emptying or illusy Symptoms of precipitating factors

  • 8/7/2019 Management of DKA Presentation

    17/46

    y TABLEFactors Most Often Associated with the Development of Diabetic Ketoacidosis

    y Factor

    Approximate frequency(%)y Infection

    35y Omission of insulin or inadequate insulin

    30y Initial presentation of diabetes mellitus

    20y Medical illness

    10y Unknown

    5

  • 8/7/2019 Management of DKA Presentation

    18/46

    y Signs

    y Signs of volume depletion

    y

    Tachycardia, hypotensiony Dry mucusmembrane, reduced skin turgor

    y Tachypnea, kussmauls respiration

    y Acetone breath

    y

    Abdominal tendernesy Altered mental status

  • 8/7/2019 Management of DKA Presentation

    19/46

    y Lab abnormality

    y Serum glucose

    y

    Elevated usually < 600 mg/dl. Could be >900mg/dl incomatose pt. why?

    y Could be normal euglycemic DKA

    y Starvation

    y Pregnancy

    y Liver diseasey Prior Rx with insulin

  • 8/7/2019 Management of DKA Presentation

    20/46

    y Serum electrolytesy Na

    y K variable

    y Py Bicarbonate-low

    Not the total body amount reflected

    y BUN,Cry Could be elevated b/c of volume depletion

    y Acetoacetate falsely elevates Cr

    y CBCy Leucocytosis-b/c of increased cortisol and cathecolamines

    y Can indicate infection

  • 8/7/2019 Management of DKA Presentation

    21/46

    y U/A

    y Urine ketone

    y UTI

    y Diabetic nephropathy

    y Plasma osmolality

    y Calculated as described before

    y Usu in DKA 300-320

    y Serum ketones

    y Nitropruside isnot a good method

    y False negative b/c B-OHB is not detected by nitroprusside

    y False positive with drugs like captopril,pencillamine,mesna

  • 8/7/2019 Management of DKA Presentation

    22/46

    y ABGy ECGy PH and bicarbonate

    y

    Bicarbonate12Additional lab studies

    y Urine culturey Sputum culturey Blood culturey CXRy A1Cy Amylase lipase

  • 8/7/2019 Management of DKA Presentation

    23/46

    y DDX

    y Alcoholic ketoacidosis

    y

    Starvation ketosisy Anion gap acidosises

    such asy Lactic acidosis

    y

    Salicylate intoxicationy Methanol/ethylene glycol intoxication

    y Rhabdomyolysis

  • 8/7/2019 Management of DKA Presentation

    24/46

    Table :Diagnostic criteria for DKA and classifications

    parameters Mild Moderate Severe

    Plasma glucose(mg/dl) >250 >250 >250

    Arterial PH 7.25-7.30 7.00-7.24 12 >12Mentation alert Alert/drowsy Stupor/coma

  • 8/7/2019 Management of DKA Presentation

    25/46

    TREATMENTy Initial evaluation

    y ABC

    y

    Mentationaltered-NG Tube

    y Volume status

    y Precipitating factors

    May need emergency Rx

  • 8/7/2019 Management of DKA Presentation

    26/46

    Goals of Rx

    y Improving circulatory volume and tissue perfusion

    y

    Reducing blood glucose and serum osmolality to normallevel

    y Clearing ketone from serum and urine at a steady state

    y Correcting the electrolyte imbalance

    y

    Identifying precipitating factors

  • 8/7/2019 Management of DKA Presentation

    27/46

    Components of Rx

    y Fluid

    y

    Insuliny electrolytes

  • 8/7/2019 Management of DKA Presentation

    28/46

    FLUID MXy It will

    y Increase intra vascular volume

    y

    Decrease BG (30-70mg/l) trough increase insuliny Hemodilution sensitivity

    y Urinary loss

    y Decrease counter regulatory hormones

    The fluid deficit should be corrected over 24hrs

  • 8/7/2019 Management of DKA Presentation

    29/46

    y Rate depends on Pt volume status

    Generally 10-15ml/Kg NS

    Roughly the fluid can be given like thisy 1L-30 min

    y 1L-2hrs

    y 1L-4hrs

    y 1L-6hrsy Then 1L every 6 hrs

  • 8/7/2019 Management of DKA Presentation

    30/46

    y Type of fluid depends on

    y Glucose level

    y

    Osmolalityy Electrolyte composition

    So initially NS then NS

    when BG

  • 8/7/2019 Management of DKA Presentation

    31/46

    Fluid initially then insulin Vs simultaneous??????

  • 8/7/2019 Management of DKA Presentation

    32/46

    INSULINMultiple dosing styles

    1. 0.1u/kg bolus followed by 0.1u/kg continuous infusion

    2. 0.14u/kg continuous infusion3. S C administration for mild DKA

    0.3u/kg followed by 0.1u/kg till BG

  • 8/7/2019 Management of DKA Presentation

    33/46

    4.??our protocol

    0.3u/kg 1/2iv 1/2im/sc

    Then 0.1u/kg im/sc q hr till BG is

  • 8/7/2019 Management of DKA Presentation

    34/46

    After resolution

    y Naive Pts 0.5-0.8u/kg calculated to be given as

    combination with 2/3 M and 1/3Ey Known diabetics put on the previous dose

    NB :regular insulin and the standing should overlap for1-2 hr

  • 8/7/2019 Management of DKA Presentation

    35/46

    y Sliding scale

    y BG q 4 hr and for every 50mg/dl increase above

    150mg/dl increase the insulin by 5iu up to a maximum of20iu

    y For pts not feeding,in stressful condition

    Standing dose with correction???

  • 8/7/2019 Management of DKA Presentation

    36/46

    ELECTROLYTESy Potassium

    y 5.3meq/ly Give insuliny No k

    So k replacement is when serum k is

  • 8/7/2019 Management of DKA Presentation

    37/46

    y Bicarbonate

    Not routine

    I

    ndicationsy PH

  • 8/7/2019 Management of DKA Presentation

    38/46

    y Phosphorous

    y Not routine

    y

    Indicationsy Cardiac dysfunction

    y Hemolytic anemia

    y Resp depression

    y Serum level

  • 8/7/2019 Management of DKA Presentation

    39/46

  • 8/7/2019 Management of DKA Presentation

    40/46

    DKA RESOLUTONy General improvement in sx

    y Pt able to feed

    y Normal anion gap 7.3

  • 8/7/2019 Management of DKA Presentation

    41/46

  • 8/7/2019 Management of DKA Presentation

    42/46

    Cerebral edema

    Dxic criteria(murei etal)y

    Abnormal response to painy Decorticate,decerebrate posturing

    y CN palsy

    y Abnormal resp pattern

    y Fluctuating LOC

    y Sustained bradycardya

    y Incontinence

    y More non specific-vomiting, headache, lethargy, elevated DBP

  • 8/7/2019 Management of DKA Presentation

    43/46

    y RX of cerebral oedema

    y Mannitol 0.5-1gm/kg over 15-30 min, if no response repeatafter 20-30 min

    y 3%Saline 5-10mg/kg over 30min

    y Hyper ventilation

    y Surgical

  • 8/7/2019 Management of DKA Presentation

    44/46

    Special considerations

    pregnancyy

    fetal mortality as high as 30% and increased to 60% when theDKA is associated with coma

    Childreny be alert to headache and reduced LOC

  • 8/7/2019 Management of DKA Presentation

    45/46

    SICK DAYRULEy Golden rule Never stop taking your insulin,b/c when

    you are sick the body sugar increases

    y Foods and drinks-take non sugary fluids, continueeating

    y Blood glucose and urinary ketone q2-4hr

    y Insulin mxy BG>7mmol/l-increase the usual insulin by 10%

    y UK +ve-increase insulin by 20% of the daily dosey Calculate and take a correction insulin dose

    could be repeated q2-4hr

  • 8/7/2019 Management of DKA Presentation

    46/46

    THE END

    ??????????